GSK2981278

inverse agonist of RORgamma

Also Known As:

Benzenesulfonamide, N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-((tetrahydro-2H-pyran-4-yl)methoxy)-; N-(4-Ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-(tetrahydro-2H-pyran-4-ylmethoxy)benzenesulfonamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Freudenberg, J M: 1 article (01/2018)
2.	Gupta, A: 1 article (01/2018)
3.	Kang, E G: 1 article (01/2018)
4.	Siemetzki, H: 1 article (01/2018)
5.	Wigger-Alberti, W: 1 article (01/2018)
6.	Wu, S: 1 article (01/2018)
7.	Yamaguchi, Y: 1 article (01/2018)
8.	von Mackensen, Y-L: 1 article (01/2018)

Related Diseases

1.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/2018 - "A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test."

Related Drugs and Biologics

1.	Ointments (Pastes)